Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in Children

(2012) S. Loos et al.   CLINICAL INFECTIOUS DISEASES

Should all adult patients with diarrhoea-associated HUS receive plasma exchange?

(2012) Henrik Birn et al.   LANCET

Should all adult patients with diarrhoea-associated HUS receive plasma exchange?

(2012) Costas Fourtounas   LANCET

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

(2011) A.-l. Stahl et al.   BLOOD

Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study

(2011) Edin Colic et al.   LANCET

The German 2011 epidemic of Shiga toxin-producing E. Coli--the nephrological view

(2011)   NEPHROLOGY DIALYSIS TRANSPLANTATION

Eculizumab in Severe Shiga-Toxin–Associated HUS

(2011) Anne-Laure Lapeyraque et al.   NEW ENGLAND JOURNAL OF MEDICINE

Origins of theE. coliStrain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany

(2011) David A. Rasko et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany

(2011) Christina Frank et al.   NEW ENGLAND JOURNAL OF MEDICINE

German Outbreak ofEscherichia coliO104:H4 Associated with Sprouts

(2011) Udo Buchholz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak

(2010) Emily W. Piercefield et al.   ARCHIVES OF INTERNAL MEDICINE

Acute Neurological Involvement in Diarrhea-Associated Hemolytic Uremic Syndrome

(2010) S. Nathanson et al.   Clinical Journal of the American Society of Nephrology

Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the apheresis applications committee of the American Society for Apheresis

(2010) Zbigniew M. Szczepiorkowski et al.   JOURNAL OF CLINICAL APHERESIS

Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification

(2010) Susanne Stampf et al.   STATISTICS IN MEDICINE

Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome

(2009) J. M. Thurman et al.   Clinical Journal of the American Society of Nephrology

Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome

(2009) Dorothea Orth et al.   JOURNAL OF IMMUNOLOGY

Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease

(2009) Lowell J. Lo et al.   KIDNEY INTERNATIONAL

Eculizumab for Atypical Hemolytic–Uremic Syndrome

(2009) Jens Nürnberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apheresis Technologies and Clinical Applications: The 2007 International Apheresis Registry

(2009) Paul S Malchesky et al.   THERAPEUTIC APHERESIS AND DIALYSIS